Edition:
United States

People: Protalix Biotherapeutics Inc (PLX)

PLX on American Stock Exchange

0.61USD
16 Dec 2017
Change (% chg)

$-0.01 (-0.92%)
Prev Close
$0.62
Open
$0.62
Day's High
$0.62
Day's Low
$0.61
Volume
741,056
Avg. Vol
1,074,128
52-wk High
$1.51
52-wk Low
$0.28

Palash, Tzvi 

Mr. Tzvi Palash is Chief Operating Officer of Protalix BioTherapeutics Inc. Mr. Maimon joined Protalix Ltd. in October 2006 as its Chief Financial Officer and became our Vice President and Chief Financial Officer in 2006. Prior to joining Protalix, from 2002 to 2006, he served as the Chief Financial Officer of Colbar LifeScience Ltd., or Colbar, a biomaterial company focusing on aesthetics, where he led all of the corporate finance activities, fund raisings and legal aspects of Colbar including the sale of Colbar to Johnson and Johnson (NYSE:JNJ). Mr. Maimon has a B.A. in accounting from the City University of New York and an MBA from Tel Aviv University, and he is a Certified Public Accountant in the United States (New York State) and Israel.

Basic Compensation

Total Annual Compensation, USD 283,669
Restricted Stock Awards, USD 113,161
Long-Term Incentive Plans, USD --
All Other, USD 85,933
Fiscal Year Total, USD 482,763

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Shlomo Yanai

--

Moshe Manor

205,733

Yossi Maimon

859,997

Tzvi Palash

482,763

Yoseph Shaaltiel

775,897

Einat Almon

678,820
As Of  30 Dec 2014